Holdings

Omega Fund Management, LLC

As of Sep 30, 2026, Omega Fund Management, LLC reported 10 positions worth US$125M. Largest: Nuvation Bio Inc., Bicara Therapeutics Inc. and Beta Bionics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Nuvation Bio Inc.7.15MUS$40M−930KSep 30, 2026
Bicara Therapeutics Inc.1.76MUS$32.8M−62,238Sep 30, 2026
Beta Bionics, Inc.962KUS$18.3M−354KSep 30, 2026
BridgeBio Oncology Therapeutics, Inc.3.29MUS$13.5Mno changeSep 30, 2026
Kestra Medical Technologies, Ltd.362KUS$10.3M−660KSep 30, 2026
Immunic, Inc.430KUS$4MnewSep 30, 2026
Sana Biotechnology, Inc.844KUS$2.46Mno changeSep 30, 2026
ImageneBio, Inc.455KUS$2.09Mno changeSep 30, 2026
enGene Holdings Inc.876KUS$1.75Mno changeSep 30, 2026
Odyssey Therapeutics, Inc.2,893US$64,282no changeSep 30, 2026